Healthcare
Tactile Systems Technology, Inc.(TCMD)
Live Price
Offline$26.34
+4.32% today
1Y Change
+164.19%
Window
Jun 20, 2025 โ Jun 9, 2026
- Market Cap
- $520.00M
- Revenue Growth
- +12.5%
- EPS Growth
- +16.9%
- Dividend Yield
- 0.0%
Coverage: 244 bars ยท Jun 20, 2025 โ Jun 9, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Tactile Systems Technology, Inc. (TCMD) is a Healthcare stock with a market cap of $520.00M and listed on NASDAQ. The stock last traded around $26.34 and up 164.2% across the available one-year price window (Jun 20, 2025 โ Jun 9, 2026). Baseline metrics include revenue growth of +12.5%, EPS growth of +16.9%, a dividend yield of 0.0%. What stands out right now is revenue +12.5%, EPS +16.9%, free cash flow +6.0% with operating margin 8.9% and ROIC 7.5%. Valuation is more restrained than many high-expectation growth names at P/E 26.9 and price/sales 1.6. Stock Foundry combines TCMD price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+12.5% vs +7.6% peer median
Operating Margin
Below sector median
+8.9% vs +19.4% peer median
P/E
Below sector median
26.9 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report came in below the EPS bar
2026 was reported on May 4, 2026 with an EPS surprise of -14.3% and a revenue surprise of +6.7%.
The operating story is still moving forward
Revenue is running at +12.5% and EPS at +16.9%, with operating margin around 8.9%.
The next real check-in already has a date
The next earnings event is scheduled for Aug 3, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +22.2% over the next 5 trading days and finished higher after 3 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 4, 2026 | -14.3% | +7.2% | +6.6% | +8.8% |
2026 Feb 17, 2026 | +4.5% | +17.8% | +2.1% | -2.3% |
2025 Nov 3, 2025 | +125.0% | +40.6% | +57.8% | +65.8% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TCMD
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
TCMD Max Drawdown
-32.13%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for TCMD and SPY.
Company Overview
Tactile Systems Technology, Inc.
NASDAQ Global Market
Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
- Leadership
- Sheri Louise Dodd
- IPO Date
- Jul 28, 2016
- Employees
- 1.0k
- Street Address
- 3701 Wayzata Boulevard
- Mailing
- Minneapolis, MN, 55416
- Region
- Minneapolis, MN, US
- Reporting Currency
- USD
- Investor Line
- 612 355 5100
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 26.9
- EV/EBITDA
- 11.9
- Price/Sales
- 1.6
- Price/Book
- 2.3
Growth
- Revenue
- +12.5%
- EPS
- +16.9%
- Free Cash Flow
- +6.0%
Profitability
- Gross Margin
- 75.2%
- Operating Margin
- 8.9%
- Net Margin
- 5.8%
- ROE
- 9.3%
- ROIC
- 7.5%
Balance Sheet
- Debt/Equity
- 0.07
- Current Ratio
- 4.03
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.